Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Cash from Investing Activities (2021 - 2025)

Tenon Medical (TNON) has 5 years of Cash from Investing Activities data on record, last reported at -$639000.0 in Q3 2025.

  • For Q3 2025, Cash from Investing Activities fell 514.42% year-over-year to -$639000.0; the TTM value through Sep 2025 reached -$706000.0, down 124.13%, while the annual FY2024 figure was -$186000.0, 103.03% down from the prior year.
  • Cash from Investing Activities reached -$639000.0 in Q3 2025 per TNON's latest filing, down from $37000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $4.7 million in Q1 2023 and bottomed at -$8.2 million in Q2 2022.
  • Average Cash from Investing Activities over 5 years is -$147928.6, with a median of -$27500.0 recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: soared 140.22% in 2024, then plummeted 514.42% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $3.4 million in 2021, then tumbled by 30.7% to $2.3 million in 2022, then plummeted by 103.93% to -$92000.0 in 2023, then skyrocketed by 140.22% to $37000.0 in 2024, then plummeted by 1827.03% to -$639000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$639000.0 in Q3 2025, $37000.0 in Q4 2024, and -$104000.0 in Q3 2024.